JP2024540604A5 - - Google Patents
Info
- Publication number
- JP2024540604A5 JP2024540604A5 JP2024529917A JP2024529917A JP2024540604A5 JP 2024540604 A5 JP2024540604 A5 JP 2024540604A5 JP 2024529917 A JP2024529917 A JP 2024529917A JP 2024529917 A JP2024529917 A JP 2024529917A JP 2024540604 A5 JP2024540604 A5 JP 2024540604A5
- Authority
- JP
- Japan
- Prior art keywords
- cdr
- seq
- indicated
- antigen
- identity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163281347P | 2021-11-19 | 2021-11-19 | |
| US63/281,347 | 2021-11-19 | ||
| US202263392474P | 2022-07-26 | 2022-07-26 | |
| US63/392,474 | 2022-07-26 | ||
| PCT/US2022/050472 WO2023091712A1 (en) | 2021-11-19 | 2022-11-18 | Bispecific antibodies targeting cd137 and uses thereof for anti-cancer immunotherapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024540604A JP2024540604A (ja) | 2024-10-31 |
| JP2024540604A5 true JP2024540604A5 (enExample) | 2025-10-24 |
Family
ID=86397821
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024529917A Pending JP2024540604A (ja) | 2021-11-19 | 2022-11-18 | Ｃｄ１３７を標的とする二重特異性抗体、及び抗がん免疫療法のためのその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250026841A1 (enExample) |
| EP (1) | EP4433511A4 (enExample) |
| JP (1) | JP2024540604A (enExample) |
| KR (1) | KR20240101629A9 (enExample) |
| AU (1) | AU2022389917A1 (enExample) |
| CA (1) | CA3237165A1 (enExample) |
| IL (1) | IL312715A (enExample) |
| MX (1) | MX2024005999A (enExample) |
| WO (1) | WO2023091712A1 (enExample) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2438442B1 (en) * | 2008-12-01 | 2017-08-09 | Laboratory Corporation of America Holdings | Methods and assays for measuring p95 and/or p95 complexes in a sample and antibodies specific for p95 |
| US20100233732A1 (en) * | 2009-01-15 | 2010-09-16 | Laboratory Corporation Of America Holdings | Methods of Determining Patient Response By Measurement of HER-2 Expression |
| MX2018015022A (es) * | 2016-06-07 | 2019-08-14 | Biogen Int Neuroscience Gmbh | Métodos para el tratamiento de la enfermedad de alzheimer. |
| CN109843926B (zh) * | 2016-09-30 | 2023-01-20 | 豪夫迈·罗氏有限公司 | 针对cd3的双特异性抗体 |
| BR112021026309A2 (pt) * | 2019-06-26 | 2022-06-07 | Ap Biosciences Inc | Anticorpos para ativação de células t |
| CN118638240A (zh) * | 2019-07-26 | 2024-09-13 | 柳韩洋行 | 抗her2/抗4-1bb双特异性抗体及其用途 |
| KR20220145859A (ko) * | 2020-02-28 | 2022-10-31 | 상하이 헨리우스 바이오테크, 인크. | 항cd137 작제물, 다중 특이적 항체 및 그 용도 |
| JP2023517234A (ja) * | 2020-03-09 | 2023-04-24 | アブセレラ バイオロジクス インコーポレイテッド | 抗コロナウイルス抗体および使用の方法 |
-
2022
- 2022-11-18 CA CA3237165A patent/CA3237165A1/en active Pending
- 2022-11-18 EP EP22896552.1A patent/EP4433511A4/en active Pending
- 2022-11-18 KR KR1020247018465A patent/KR20240101629A9/ko active Pending
- 2022-11-18 JP JP2024529917A patent/JP2024540604A/ja active Pending
- 2022-11-18 WO PCT/US2022/050472 patent/WO2023091712A1/en not_active Ceased
- 2022-11-18 IL IL312715A patent/IL312715A/en unknown
- 2022-11-18 US US18/708,551 patent/US20250026841A1/en active Pending
- 2022-11-18 MX MX2024005999A patent/MX2024005999A/es unknown
- 2022-11-18 AU AU2022389917A patent/AU2022389917A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7781859B2 (ja) | 抗ｒｏｒ１抗体及び関連の二重特異性結合タンパク質 | |
| JP2024520188A5 (enExample) | ||
| JP2024515536A5 (enExample) | ||
| JP2024056687A5 (enExample) | ||
| KR20160127825A (ko) | 항-mcam 항체 및 관련된 사용 방법 | |
| RU2013142600A (ru) | Белки, связывающие специфический мембранный антиген простаты, и соответствующие композиции и способы | |
| JP2024119853A5 (enExample) | ||
| JP2021520832A5 (enExample) | ||
| US20250034273A1 (en) | Composition of multispecific antibodies targeting cadherin-17-expressing tumors and method of making and using thereof | |
| JP2024001073A5 (enExample) | ||
| JP2023506465A5 (enExample) | ||
| CN116940598A (zh) | 用于治疗表达cldn18.2的实体瘤的cldn18.2/cd3双特异性抗体 | |
| JPWO2014065402A1 (ja) | 抗ヒトｃｄ４０モノクローナル抗体及びその利用 | |
| JP7720989B2 (ja) | Ｅｇｆｒ及びｈｅｒ３を標的とする二重特異性四価抗体 | |
| JP2023522212A5 (enExample) | ||
| CN113574069A (zh) | 抗pd-l1抗体及其用途 | |
| WO2021226984A1 (zh) | 一种抗pd-1和pd-l1的四价双特异性抗体 | |
| JP2023516941A5 (enExample) | ||
| JP2022540610A5 (enExample) | ||
| US20220204644A1 (en) | Combination of her2 antibodies | |
| IL321677A (en) | Anti-PDL1 antibodies, multispecific antibodies, and methods of use | |
| JP2024508597A5 (enExample) | ||
| RU2844869C1 (ru) | Антитела против ror1 и родственные биспецифичные связывающие белки | |
| JP2024547020A5 (ja) | 多重特異性抗体、免疫コンジュゲート、抗原認識受容体、免疫応答性細胞、薬物組成物、核酸、ベクター、宿主細胞、方法、及びキット | |
| WO2026009973A1 (ja) | 抗変異ｃａｌｒ抗体を含む組成物および抗体の作製方法 |